
Jonathan Block
Stock Analyst at Stifel Nicolaus
(4.09)
# 1,701
Out of 5,144 analysts
616
Total ratings
49.6%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Downgraded: Hold | $180 → $165 | $145.34 | +13.53% | 9 | Nov 17, 2026 | |
| TNDM Tandem Diabetes Care | Upgraded: Buy | $22 → $26 | $17.06 | +52.40% | 7 | Nov 17, 2026 | |
| SENS Senseonics Holdings | Reiterated: Hold | $9 → $10 | $10.16 | -1.57% | 6 | Nov 10, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $33 | $25.85 | +27.66% | 44 | Nov 9, 2026 | |
| TRUP Trupanion | Reiterated: Hold | $29 → $34 | $36.55 | -6.98% | 46 | Nov 9, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $31 | $23.70 | +30.80% | 27 | Nov 5, 2026 | |
| ZTS Zoetis | Reiterated: Hold | $85 | $83.48 | +1.82% | 62 | Nov 5, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Buy | $675 → $700 | $690.24 | +1.41% | 69 | Nov 3, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $85 | $59.41 | +43.07% | 44 | Nov 3, 2026 | |
| DXCM DexCom | Reiterated: Buy | $95 | $82.04 | +15.80% | 8 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $163.46 | +7.06% | 106 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $14.72 | +49.46% | 9 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 | $237.85 | -1.20% | 13 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $60.72 | +15.28% | 39 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.60 | +62.79% | 44 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 → $95 | $82.94 | +14.54% | 34 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $40 | $13.88 | +188.29% | 17 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $0.6996 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $45 | $243.25 | n/a | 22 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 | $0.0002 | n/a | 1 | Jul 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $41 → $47 | $156.50 | n/a | 3 | May 15, 2017 |
Insulet
Nov 17, 2026
Downgraded: Hold
Price Target: $180 → $165
Current: $145.34
Upside: +13.53%
Tandem Diabetes Care
Nov 17, 2026
Upgraded: Buy
Price Target: $22 → $26
Current: $17.06
Upside: +52.40%
Senseonics Holdings
Nov 10, 2026
Reiterated: Hold
Price Target: $9 → $10
Current: $10.16
Upside: -1.57%
Elanco Animal Health
Nov 9, 2026
Reiterated: Buy
Price Target: $33
Current: $25.85
Upside: +27.66%
Trupanion
Nov 9, 2026
Reiterated: Hold
Price Target: $29 → $34
Current: $36.55
Upside: -6.98%
Envista Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $31
Current: $23.70
Upside: +30.80%
Zoetis
Nov 5, 2026
Reiterated: Hold
Price Target: $85
Current: $83.48
Upside: +1.82%
IDEXX Laboratories
Nov 3, 2026
Reiterated: Buy
Price Target: $675 → $700
Current: $690.24
Upside: +1.41%
Inspire Medical Systems
Nov 3, 2026
Reiterated: Buy
Price Target: $85
Current: $59.41
Upside: +43.07%
DexCom
Oct 30, 2026
Reiterated: Buy
Price Target: $95
Current: $82.04
Upside: +15.80%
Oct 29, 2026
Reiterated: Buy
Price Target: $175
Current: $163.46
Upside: +7.06%
Oct 28, 2026
Reiterated: Buy
Price Target: $22
Current: $14.72
Upside: +49.46%
Oct 2, 2026
Reiterated: Hold
Price Target: $235
Current: $237.85
Upside: -1.20%
Oct 1, 2026
Reiterated: Buy
Price Target: $70
Current: $60.72
Upside: +15.28%
Aug 7, 2026
Reiterated: Hold
Price Target: $14
Current: $8.60
Upside: +62.79%
Aug 5, 2026
Reiterated: Hold
Price Target: $84 → $95
Current: $82.94
Upside: +14.54%
Mar 13, 2026
Reiterated: Hold
Price Target: $2 → $40
Current: $13.88
Upside: +188.29%
Jan 7, 2022
Reiterated: Buy
Price Target: $10 → $9
Current: $0.6996
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $55 → $45
Current: $243.25
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $41 → $47
Current: $156.50
Upside: n/a